The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Targeted Biomarker Market Research Report 2025
Synopsis
Targeted Biomarker refers to biochemical indicators that can mark changes or possible changes in the structure or function of systems, organs, tissues, cells, and subcellular cells, and has a wide range of uses.
The global Targeted Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Targeted Biomarker can be used to diagnose diseases, determine stage of disease, or to evaluate the safety and effectiveness of new drugs or treatments in target populations.
This report aims to provide a comprehensive presentation of the global market for Targeted Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Biomarker.
Report Scope
The Targeted Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
bioMerieux
IntegraGen
Myriad Genetics
Protagen
Qiagen
PerkinElmer
Merck Millipore
Bio-Rad Laboratories
Enzo Biochem
EKF Diagnostics
Meso Scale Diagnostics, LLC.
Segment by Type
Safety biomarker
Efficacy biomarker
Validation biomarker
Segment by Application
Diagnostics development
Drug discovery & development
Personalized medicine
Disease risk assessment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Targeted Biomarker refers to biochemical indicators that can mark changes or possible changes in the structure or function of systems, organs, tissues, cells, and subcellular cells, and has a wide range of uses.
The global Targeted Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Targeted Biomarker can be used to diagnose diseases, determine stage of disease, or to evaluate the safety and effectiveness of new drugs or treatments in target populations.
This report aims to provide a comprehensive presentation of the global market for Targeted Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Biomarker.
Report Scope
The Targeted Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
bioMerieux
IntegraGen
Myriad Genetics
Protagen
Qiagen
PerkinElmer
Merck Millipore
Bio-Rad Laboratories
Enzo Biochem
EKF Diagnostics
Meso Scale Diagnostics, LLC.
Segment by Type
Safety biomarker
Efficacy biomarker
Validation biomarker
Segment by Application
Diagnostics development
Drug discovery & development
Personalized medicine
Disease risk assessment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Safety biomarker
1.2.3 Efficacy biomarker
1.2.4 Validation biomarker
1.3 Market by Application
1.3.1 Global Targeted Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics development
1.3.3 Drug discovery & development
1.3.4 Personalized medicine
1.3.5 Disease risk assessment
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Biomarker Market Perspective (2019-2030)
2.2 Targeted Biomarker Growth Trends by Region
2.2.1 Global Targeted Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Targeted Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Targeted Biomarker Market Dynamics
2.3.1 Targeted Biomarker Industry Trends
2.3.2 Targeted Biomarker Market Drivers
2.3.3 Targeted Biomarker Market Challenges
2.3.4 Targeted Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Biomarker Players by Revenue
3.1.1 Global Top Targeted Biomarker Players by Revenue (2019-2024)
3.1.2 Global Targeted Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Biomarker Revenue
3.4 Global Targeted Biomarker Market Concentration Ratio
3.4.1 Global Targeted Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Biomarker Revenue in 2023
3.5 Targeted Biomarker Key Players Head office and Area Served
3.6 Key Players Targeted Biomarker Product Solution and Service
3.7 Date of Enter into Targeted Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Biomarker Breakdown Data by Type
4.1 Global Targeted Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Targeted Biomarker Forecasted Market Size by Type (2025-2030)
5 Targeted Biomarker Breakdown Data by Application
5.1 Global Targeted Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Targeted Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted Biomarker Market Size (2019-2030)
6.2 North America Targeted Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Targeted Biomarker Market Size by Country (2019-2024)
6.4 North America Targeted Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Biomarker Market Size (2019-2030)
7.2 Europe Targeted Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Targeted Biomarker Market Size by Country (2019-2024)
7.4 Europe Targeted Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Targeted Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Targeted Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Targeted Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Biomarker Market Size (2019-2030)
9.2 Latin America Targeted Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Targeted Biomarker Market Size by Country (2019-2024)
9.4 Latin America Targeted Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Targeted Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Targeted Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Targeted Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 bioMerieux
11.1.1 bioMerieux Company Detail
11.1.2 bioMerieux Business Overview
11.1.3 bioMerieux Targeted Biomarker Introduction
11.1.4 bioMerieux Revenue in Targeted Biomarker Business (2019-2024)
11.1.5 bioMerieux Recent Development
11.2 IntegraGen
11.2.1 IntegraGen Company Detail
11.2.2 IntegraGen Business Overview
11.2.3 IntegraGen Targeted Biomarker Introduction
11.2.4 IntegraGen Revenue in Targeted Biomarker Business (2019-2024)
11.2.5 IntegraGen Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Detail
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Targeted Biomarker Introduction
11.3.4 Myriad Genetics Revenue in Targeted Biomarker Business (2019-2024)
11.3.5 Myriad Genetics Recent Development
11.4 Protagen
11.4.1 Protagen Company Detail
11.4.2 Protagen Business Overview
11.4.3 Protagen Targeted Biomarker Introduction
11.4.4 Protagen Revenue in Targeted Biomarker Business (2019-2024)
11.4.5 Protagen Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Targeted Biomarker Introduction
11.5.4 Qiagen Revenue in Targeted Biomarker Business (2019-2024)
11.5.5 Qiagen Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Detail
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Targeted Biomarker Introduction
11.6.4 PerkinElmer Revenue in Targeted Biomarker Business (2019-2024)
11.6.5 PerkinElmer Recent Development
11.7 Merck Millipore
11.7.1 Merck Millipore Company Detail
11.7.2 Merck Millipore Business Overview
11.7.3 Merck Millipore Targeted Biomarker Introduction
11.7.4 Merck Millipore Revenue in Targeted Biomarker Business (2019-2024)
11.7.5 Merck Millipore Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Detail
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Targeted Biomarker Introduction
11.8.4 Bio-Rad Laboratories Revenue in Targeted Biomarker Business (2019-2024)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Enzo Biochem
11.9.1 Enzo Biochem Company Detail
11.9.2 Enzo Biochem Business Overview
11.9.3 Enzo Biochem Targeted Biomarker Introduction
11.9.4 Enzo Biochem Revenue in Targeted Biomarker Business (2019-2024)
11.9.5 Enzo Biochem Recent Development
11.10 EKF Diagnostics
11.10.1 EKF Diagnostics Company Detail
11.10.2 EKF Diagnostics Business Overview
11.10.3 EKF Diagnostics Targeted Biomarker Introduction
11.10.4 EKF Diagnostics Revenue in Targeted Biomarker Business (2019-2024)
11.10.5 EKF Diagnostics Recent Development
11.11 Meso Scale Diagnostics, LLC.
11.11.1 Meso Scale Diagnostics, LLC. Company Detail
11.11.2 Meso Scale Diagnostics, LLC. Business Overview
11.11.3 Meso Scale Diagnostics, LLC. Targeted Biomarker Introduction
11.11.4 Meso Scale Diagnostics, LLC. Revenue in Targeted Biomarker Business (2019-2024)
11.11.5 Meso Scale Diagnostics, LLC. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
